92 results
Page 3 of 5
8-K
EX-99.1
dhob7abekx46bp0 unw
13 Jan 20
Regulation FD Disclosure
4:32pm
8-K
EX-99.1
l1bcx1
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.1
atgu bzdpfldgvhs1e
22 Nov 19
Other Events
5:01pm
424B5
yrbynmi ak2rsjk
8 Nov 19
Prospectus supplement for primary offering
5:03pm
424B5
5e5eezrm2kdzq
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
3ijtk3
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.2
n0bxfu19r5ilgeuy6p2
4 May 18
Results of Operations and Financial Condition
7:07am